x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




WIPR survey: readers back TPP data exclusivity period

19-10-2015

WIPR survey: readers back TPP data exclusivity period

m00osfoto / Shutterstock.com

A five-year period of data exclusivity available for biological drugs, as proposed in the Trans-Pacific Partnership (TPP) is long enough to encourage investment in the field, readers have said.


patent, biologics, data exclusivity, Trans-Pacific Partnership, TPP,

WIPR

Payment types accepted